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Abstract
Background: Tissue development and organ growth require constant remodeling of cell-cell contacts formed between
epithelial cells. The Hippo signaling cascade curtails organ growth by excluding the transcriptional co-activator Yes
Associated Protein 1 (YAP1) from the nucleus. Angiomotin family members recruit YAP1 to tight junctions [1], but whether
YAP1 plays a specific role outside of the nucleus is currently unknown.
Methodology/Principal Findings: The present study demonstrates that the E3 ubiquitin ligase Nedd4.2 targets
Angiomotin-like 1 (AMOTL1), a family member that promotes the formation of epithelial tight junctions, for ubiquitin-
dependent degradation. Unexpectedly, YAP1 antagonizes the function of Nedd4.2, and protects AMOTL1 against Nedd4.2-
mediated degradation. YAP1 recruits c-Abl, a tyrosine kinase that binds and phosphorylates Nedd4.2 on tyrosine residues,
thereby modifying its ubiquitin-ligase activity.
Conclusions/Significance: Our results uncover a novel function for cytoplasmic YAP1. YAP1 recruits c-Abl to protect
AMOTL1 against Nedd4.2-mediated degradation. Thus, YAP1, excluded from the nucleus, contributes to the maintenance of
tight junctions.
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Introduction
Cell proliferation during development is tightly regulated to
generate tissue and organs of defined size. Signaling cascades
involved in the control of cell division and organ size include
mTOR and the recently characterized Hippo signaling cascade
[2,3,4,5]. The Hippo pathway was initially established in flies; its
core components such as Hippo, Salvador, Warts and Mats were
subsequently identified in mammals (Mst1/2, WW45, Lats1/2
and Mob1, respectively). These four components form a kinase
cascade whereby Hippo/Mst1/2 interacts with Sav/WW45 to
phosphorylate and activate the protein complex of Wts/Lats1/2
and Mats/Mob1. The major target gene of the cascade is the
transcriptional co-activator Yorkie (or its mammalian orthologue
YAP1), which promotes cell proliferation and organ growth [6,7].
When epithelial cells reach confluence, they exhibit contact
inhibition triggered by cell-cell interactions, an event associated
with nuclear exclusion and cytoplasmic retention of YAP1. This
process is largely controlled by Hippo signaling, whereby phor-
sphorylated YAP1 by Wts/Lats1/2 is bound by the cytoplasmic
14-3-3 protein [8,9].
It has been shown that apico-basal proteins intersect with the
Hippo pathway to regulate normal tissue development
[10,11,12,13]. Tight junction (TJ) proteins, specifying apical and
baso-lateral cell domains, can suppress proliferation by sequester-
ing transcription factors [14]. Angiomotin like-1 (AMOTL1), a
coiled-coil, PDZ-binding and glutamine rich domain containing
protein [15], was recently characterized as a molecule involved in
angiogenesis and cell migration [16]. AMOTL1 localizes to tight
junctions (TJ), and directly interacts with MUPP1/Patj, an
adaptor of the Crumbs complex [17]. AMOTL1 and AMOTL2
retain YAP1 in the cytoplasm, preventing YAP1-dependent gene
activation [18]. The function of YAP1 outside the nucleus is
currently unknown, although the levels of cytoplasmic YAP1 are
tightly regulated via ubiquitin-dependent degradation by the E3
ligase SCF (b-TRCP) [19].
Here, we assign a novel role to cytoplasmic YAP1 in epithelial
cells. We demonstrate that YAP1 binds AMOTL1 and prevents it
from degradation by Nedd4.2. Nedd4.2 is a member of the
NEDD4 family of E3 ligases, that contain a carboxy-terminal
catalytic HECT (homolog to E6AP C-term) domain [20]. The
NEDD4 family of E3-ligases regulates endocytosis and degrada-
tion of many channels, receptors, and transporters. NEDD4 E3
ligases typically contain an amino-terminal C2 domain as well as
two to four WW domains that bind their substrates through
recognition of (L/P)PxY motifs [21,22,23,24]. Recent evidence
suggests that NEDD4 proteins are also involved in tight junction
assembly and the regulation of paracellular conductance in the
collecting duct of the kidney [25].
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35735We report now that Nedd4.2 targets AMOTL1 for ubiquitin-
dependent degradation. YAP1 prevents AMOTL1 degradation
through recruitment of the non-receptor tyrosine kinase c-Abl.
Phosphorylation of Nedd4.2 by c-Abl curtails its E3 ligase activity,
which results in inhibition of the ubiquitylation and degradation of
AMOTL1.
Materials and Methods
Reagents and Plasmids
MG132 (Calbiochem) was used at a concentration of 5 mM.
AMOTL1 with an N-terminal Flag tag was generated by a clone
containing the human AMOTL1 cDNA (Imagenes). Full length
human YAP1 and c-Abl cDNAs where cloned into the MluI and
NotI sites of theV5-pcDNA6 vector. The human myc-Nedd4.2
C962S (dominant negative) construct was kindly provided by Dr.
Pawson (Samuel Lunenfeld Research Institute, Mount Sinai
Hospital, Toronto, Ontario, Canada). Dominant negative
Nedd4.2 N-terminally tagged with myc was repaired to wild-type
by QuickChange (QC) mutagenesis. Single and multiple amino
acid substitutions were made using F9.AMOTL1 as template and
QC site-directed mutagenesis with overlapping PCR primers. To
create the YAP1 WW1 (
199WQDP
202 to
199AQDA
202) and WW2
(
258WLDP
261 to
258AQDA
261) mutants, as well as Nedd4.2 WW1
(
213WHRP
216 to
213AHRA
216), WW2 (
385WTRP
388 to
385ATRA
388), WW3 (
497WEDP
500 to
497AEDA
500), WW4
(
548WEDP
551 to
548AEDA
551), we used the wild-type templates
for QC site-directed mutagenesis. The Nedd4.2 phosphorylation
mutants Y71F and Y457F were generated by QC mutagenesis
using the pRK5 vector. The c-Abl cDNA was re-cloned into the
F9-pcDNA6 vector to obtain an N-terminal F9-tagged construct.
The F9.cAbl construct was used as a template to generate the
K290R kinase dead mutant, according to the manufacturer’s
protocol (Stratagene Cloning systems, La Jolla, CA). Ubiquitin was
cloned into an HA tagged pMT123 vector into the NotI and EcoRI
sites.
Short Hairpin RNA (shRNA)
The pSUPER YAP1 human RNA interference (RNAi) designed
for the target sequence 59-ccagagaatcagtcagaga-39 and the human
Nedd4.2 for the target sequence 59- ggatgagaatagagaacttgc-39.
Cell culture and Transfections
Human HEK293T and MDCK cells (received from American
Type Culture Collection, ATCC, Manassas, VA) were grown in
Dulbecco’s modified Eagle’s medium containing 10% fetal bovine
serum and antibiotics. A TransPEI transfection method (Euro-
gentec, Cologne, Germany) was used for DNA transfections of
HEK293T cells. MDCK cells were transfected with plasmid DNA
using Amaxa-nucleofection (Amaxa Biosystems, Cologne, Ger-
many). The cells were used in transient-expression experiments on
the second or third day.
Immunofluorescence
MDCK cells were fixed in 4% PFA for 20 min, permeabilized
in 0.5% Triton X-100, and blocked in PBS containing 2% horse
serum. Immunostainings for AMOTL1 and ZO-1 were performed
with a rabbit anti-AMOTL1 (1:200) and a mouse anti-ZO-1
(1:250) (Zymed). HEK293T cells were fixed in 4% PFA for
10 min, permeabilized in 0.5% Triton X-100 for 10 min and
blocked in PBS (0.5% Tween-20) containing 2% horse serum.
Immunostainings were performed using the following antibodies:
goat anti-AMOTL1 (1:100), rabbit anti-Nedd4.2 (1:150) and
mouse anti-YAP1 (1:150).
Immunoprecipitations and Western Blotting
Cells were washed with ice-cold PBS and lysed with lysis buffer
(20 mM Tris, pH 7.5, 1% Triton X-100, 50 mM NaCl, 50 mM
NaF, 15 mM Na4P2O7, 0.1 mM EDTA) supplemented with
1 mM NaVO4 and protease inhibitor mixture (Roche). After
centrifugation (15,000 g,15 min, 4uC) and ultracentrifugation
(100,000 g, 30 min, 4uC) cell lysates containing equal amounts
of total protein were incubated for 1 h at 4uC with the anti-Flag
M2 resin (Sigma) or with anti-myc antibody, followed by
incubation with 50 ml of protein A-Sepharose beads for 2 h. The
beads were then washed extensively with lysis buffer and bound
proteins were analyzed by Western blotting with the following
antibodies: M2 antibody to Flag (Sigma), mouse anti-V5 (Serotec),
mouse anti-myc 9E10 (Upstate), rabbit anti-myc A-14 (Santa
Cruz), mouse anti-HA 12CA5 (Roche), rabbit anti-phosphotyr-
osine (BD Biosciences). HEK293T lysates were blotted for the
endogenous AMOTL1, YAP1 and Nedd4.2 using the following
antibodies: rabbit anti-AMOTL1 (Abcam), mouse anti-YAP1
(Abnova) and rabbit anti-Nedd4.2 (Proteintech). Rabbit anti-
CEP164 was used as a negative control.
Ubiquitylation Assay
24 h after transfection, HEK 293T cells were washed with PBS
and lysed with RIPA buffer (1% Triton X-100, 0.5% sodium
deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM NaF, 2 mM
EDTA, 13.7 mM Na2HPO4, 6.3 mM NaH2PO4). The superna-
tant obtained after ultracentrifugation (100,000 g, 30 min, 4uC)
was used for binding to anti-Flag M2 resin for 1.5 h, washed five
times and bound proteins were resolved by SDS-PAGE. The
proteins were blotted using the mouse anti-HA (Roche).
In-gel digestion
For in-gel digestion the excised gel bands were destained with
30% ACN, shrunk with 100% ACN, and dried in a Vacuum
Concentrator (Concentrator 5301, Eppendorf, Hamburg, Ger-
many). Digests with trypsin and elastase were performed overnight
at 37uC in 0.05 M NH4HCO3 (pH 8). About 0.1 mg of protease
was used for one gel band. Peptides were extracted from the gel
slices with 95% acetonitrile and 5% formic acid and dried in a
vacuum concentrator.
Phosphopeptide enrichment
Phosphorylated peptides were enriched using TiO2 (Titan-
sphere, 5 mm particle size, GL Sciences, Japan) as recently
described for phosphopeptides [26]. Briefly, peptides were re-
dissolved in 10 mL 50% acetonitrile, 0.1% formic acid and loaded
on a TiO2 nano column (0.5 cm length, 125 mm i.d.) at a flow rate
of 2 mL/min. After washing with 20 mL 30% acetonitrile, 2%
formic acid (flow rate: 2 mL/min), phosphorylated peptides were
eluted (flow rate: 2 mL/min) with 100 mM citrate pH 9.5.
LC-MS/MS and data analysis
LC-MS/MS analysis of the eluate from the TiO2 column were
performed on a Q-TOF mass spectrometer (Agilent 6520, Agilent
Technologies) coupled to a 1200 Agilent nanoflow system via a
HPLC-Chip cube ESI interface. Peptides were separated on a
HPLC-Chip with an analytical column of 75 mm i.d. and 150 mm
length and a 40 nL trap column, both packed with Zorbax 300SB
C-18 (5 mm particle size). Peptides were elutes with a linear
acetonitrile gradient with 1% per min at a flow rate of 300 nL/
min (starting with 3% acetonitrile). The Q-TOF was operated in
the 2Ghz extended dynamic range mode. MS/MS analyses were
performed using data-dependent acquisition mode. After a MS
YAP1 Protects AMOTL1 from Degradation
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MS/MS (2 spectra/s). Singly charged precursor ions were
excluded from selection. Internal calibration was applied using
two reference masses. Mascot Distiller 2.3 was used for raw data
processing and for generating peak lists, essentially with standard
settings for the Agilent Q-Tof. Mascot Server 2.3 was used for
Figure 1. Nedd4.2 interacts with AMOTL1 and mislocalizes AMOTL1 from tight junctions. A, Nedd4.2 reduces AMOTL1 protein levels. Co-
expression of myc-tagged Nedd4.2 (myc.Nedd4.2) decreased Flag-tagged AMOTL1 (F.AMOTL1), occasionally to very low protein levels (lane 2). B,
AMOTL1 interacts with Nedd4.2. HEK 293T cells were transfected with constructs encoding F.AMOTL1, myc.GFP, or myc.Nedd4.2. Cell lysates were
probed with anti-myc and anti-Flag antibodies. Precipitation of F.AMOTL1 immobilized myc.Nedd4.2, but not myc.GFP, while precipitated F.GFP did
not bind myc.Nedd4.2. C, Binding of endogenous AMOTL1 to Nedd4.2 was detected with anti-AMOTL1 and anti-Nedd4.2 antibodies, respectively.
CEP164 was used as a negative control. D, AMOTL1 co-localizes mostly at the plasma membrane with Nedd4.2 in HEK293T cells. E, MDCK cells were
transfected either with empty vector or Nedd4.2. Cells were then stained for endogenous AMOTL1 (grayscale) and the tight junction marker, ZO-1
(red). AMOTL1 is localized to tight junctions together, with ZO-1. Note that in dividing cells (yellow arrowheads) less ZO-1 as well as AMOTL1 are
observed at junctions. When Nedd4.2 is added, endogenous ZO-1 as well as AMOTL1 are mislocalized from tight junctions and appear mostly in the
cytoplasm. Scale bars represent 20 mm.
doi:10.1371/journal.pone.0035735.g001
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tolerance: 20 ppm, MS/MS mass tolerance: 0.05 Da, enzyme:
‘‘trypsin’’ with 2 uncleaved sites allowed for trypsin, and ‘‘none’’
for elastase, variable modifications: Carbamidomethyl (C), Gln-
.pyroGlu (N-term. Q), oxidation (M), and phosphorylation
(STY). For protein and peptide identification a small custom
database containing the protein sequences of Nedd4.2 was used.
All MS/MS spectra identified as phosphorylated were validated
manually.
Results
YAP1 blocks ubiquitylation and degradation of AMOTL1
by Nedd4.2
Co-expression of AMOTL1 with Nedd4.2 resulted in a drastic
reduction of AMOTL1 protein levels in HEK 293T cells; in some
experiments AMOTL1 became virtually undetectable (Fig. 1A).
Co-immunoprecipitation experiments revealed that the two
proteins form a complex (Fig. 1B). Importantly, we could detect
weak binding (Fig. 1C) and membrane co-localization of the
endogenous Nedd4.2 and AMOTL1 proteins in HEK293T cells
(Fig. 1D). Immunofluorescence experiments in MDCK cells
showed that the endogenous AMOTL1 protein colocalises with
ZO-1, a tight junction marker (Fig. 1E), but both markers are
absent in dividing cells (yellow arrowheads in Fig. 1E). However,
the presence of Nedd4.2 reduces the levels of AMOTL1, which
appears less localized to tight junctions and is mostly cytoplasmic.
In this case, ZO-1 begins to appear more diffuse and its presence
at tight junctions is less pronounced (Fig. 1E). These two findings
suggest that the absence of AMOTL1 tends to destabilize tight
junctions. The cytoplasmic region of AMOTL1 contains two
conventional WW domain binding PPxY (PY) motifs at amino
acid positions 310–313 and 367–370 and one unconventional
LPxY motif at 188–191 (Fig. S1). Since the WW domains of
Nedd4.2 (Fig. S1) recognize PPxY motifs, we asked whether
mutation of the two AMOTL1 PPxY motifs affected the
interaction with Nedd4.2. Mutation of single AMOTL1 PPxY
motifs to alanines had no detectable effect (data not shown),
Figure 2. The WW3 domain of Nedd4.2 interacts with AMOTL1.
A, The two PPxY motifs of AMOTL1 (PY1: PPEY, amino acid 310–313, and
PY2: PPEY, amino acid 367–370) are important for the interaction with
Nedd4.2. Precipitation of wild type F.AMOTL1 immobilized both
myc.Nedd4.2 and V5.YAP1 (left panel), while precipitation of mutant
F.AMOTL1PY1/2, lacking both PPxY motifs, immobilized V5.YAP1, but
only small amounts of myc.Nedd4.2 (right panel). B, The WW1, WW2,
WW3 and WW4 domains of Nedd4.2 were mutated, and co-expressed
with Flag-tagged AMOTL1. Only the interaction between the myc.-
Nedd4.2 WW3 and AMOTL1 was decreased, indicating that this domain
interacts with AMOTL1.
doi:10.1371/journal.pone.0035735.g002
Figure 3. Nedd4.2 targets AMOTL1 for proteasomal degrada-
tion. HEK 293T cells were transfected with AMOTL1, Nedd4.2 and YAP1,
as indicated. Cells were treated with 5 mM MG132 for 120 min. Lysates
were analyzed by Western blotting. AMOTL1, Nedd4.2 and YAP1 were
detected with anti-Flag, anti-myc and anti-V5 antibodies, respectively.
Actin was used as a loading control.
doi:10.1371/journal.pone.0035735.g003
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PLoS ONE | www.plosone.org 5 April 2012 | Volume 7 | Issue 4 | e35735whereas substitution of both motifs (AMOTL1
310–313A/367–370A)
strongly decreased the interaction with Nedd4.2 (Fig. 2A).
However, in this experiment, mutation of the two PPxY motifs
of AMOTL1 did not affect the interaction with YAP1, suggesting
that the PPxY mutations did not generally abolish protein-protein
interactions (Fig. 2A). Site-directed mutagenesis of each of the four
Nedd4.2 WW domains revealed that the third WW domain
(WW3) of Nedd4.2 mediates the interaction with AMOTL1
(Fig. 2B). Based on these findings, we assumed that the E3
ubiquitin ligase Nedd4.2 targets AMOTL1 to the proteasome. To
confirm this hypothesis, we probed whether inhibition of
proteasomal degradation with MG132 leads to the accumulation
of AMOTL1. Indeed, MG132 treatment caused partial accumu-
lation of AMOTL1 in the presence of Nedd4.2 (Fig. 3).
Furthermore, in vivo assays revealed that AMOTL1 was strongly
ubiquitylated in the presence of wild-type Nedd4.2, but not in the
presence of the dominant-negative (DN) mutant of Nedd4.2
(Fig. 4A). YAP1 protected AMOTL1 against Nedd4.2-mediated
protein turnover in a dose-dependent manner (Fig. S2) and
antagonized the ubiquitylation of AMOTL1 mediated by Nedd4.2
(Fig. 4A), suggesting that AMOTL1 recruits YAP1 to escape
ubiquitin-dependent degradation. Importantly, we found that the
same functional rules govern the relationship among endogenous
AMOTL1, YAP1 and Nedd4.2. For this, we used shRNA to knock
down YAP1 or Nedd4.2 in HEK293T cells that strongly express
AMOTL1 [27]. We found that even partial depletion of YAP1
effectively reduces the amount of endogenous AMOTL1, whereas
knockdown of endogenous Nedd4.2 maintains AMOTL1 protein
levels (Fig. 5).
YAP1, via its WW1 domain, binds and protects AMOTL1
We then asked how YAP1 protects AMOTL1. First, we
corroborated our observation that overexpressed AMOTL1 and
YAP1 interact physically (Fig. 2A) by examining their endogenous
interaction. We found that YAP1 strongly precipitates AMOTL1
(Fig. S3A) and that the two proteins co-localize mostly at the
plasma membrane (Fig. S3B). Like Nedd4.2, YAP1 contains two
WW domains (Fig. S1). Therefore, we generated mutants for these
two domains (WW1 and WW2). Co-expression of AMOTL1 and
either of WW1- or WW2-mutant versions of YAP1 demonstrated
that the interaction with AMOTL1 is mediated by the WW1
domain (Fig. S3C). In agreement with these findings, only the wild
Figure 4. YAP1 inhibits AMOTL1 degradation via its first WW domain. A, Nedd4.2 facilitates the ubiquitylation of AMOTL1. HEK293T cells
were transfected with AMOTL1, Nedd4.2 and YAP1, as indicated. AMOTL1 was precipitated and probed for incorporated HA-tagged ubiquitin.
AMOTL1 levels were determined by re-probing the blot with anti-Flag antibody. A catalytically inactive (DN) Nedd4.2 was used as a control for ligase
activity. B, Wild type YAP1 and the YAP1WW2 mutant, but not the YAP1WW1 mutant, reduce ubiquitylation of AMOTL1. HA-tagged ubiquitin
(HA.Ubiquitin) and expression vectors, as indicated, were co-expressed in HEK293T cells. AMOTL1 was precipitated by M2 sepharose beads, and then
probed with antibody to HA to identify ubiquitylated AMOTL1. C, YAP1 protects both single and double AMOTL1 PPxY mutants against Nedd4.2-
mediated ubiquitylation. Either of AMOTL1
310–313A (F.AMOTL1PY1), AMOTL1
367–370A (F.AMOTL1PY2) or AMOTL1
310–313A/367–370A (F.AMOTL1PY1/2)
were co-expressed with different combinations of HA.Ubiquitin, myc.Nedd4.2, V5.YAP1 and V5.YAP1 WW1, as indicated. Cell extracts were
precipitated with M2 beads and blotted with anti-HA antibody. In blots for ubiquitin, brackets indicate molecular weights that correspond to poly- or
oligo-ubiquitylation of AMOTL1. Poly-ubiquitylation results in complexes with molecular weights above 220 kDa which signal degradation of the
protein by the 26S proteasome. Complexes between 100 kDa and 220 kDa indicate oligo-ubiquitylated peptides that are generally not degraded by
the 26S proteasome.
doi:10.1371/journal.pone.0035735.g004
Figure 5. Depletion of endogenous YAP1 or Nedd4.2 affects
endogenous AMOTL1 levels. HEK293T cells were transiently
transfected with either YAP1 or Nedd4.2 shRNA. Even a small reduction
of YAP1 results in almost complete absence of AMOTL1. However
depletion of Nedd4.2 maintains AMOTL1 levels. Actin was used as a
loading control.
doi:10.1371/journal.pone.0035735.g005
Figure 6. YAP1-AMOTL1 binding requires the AMOTL1 motifs
LPTY and the PPEY. Either of Flag-tagged AMOTL1
188–191A (LY: LPTY,
aminoacids188–191),AMOTL1
188–191A/310–313A(LY/PY1:LPTY,aminoacids
188–191 and PPEY, amino acids 310–313) or AMOTL1
188–191A/367–370A
(LY/PY2: LPTY, amino acids 188–191 and PPEY, amino acids 367–370)
mutants were used to precipitate YAP1. Immunoblotting was carried out
using the indicated antibodies.
doi:10.1371/journal.pone.0035735.g006
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35735Figure 7. c-Abl phosphorylates Nedd4.2 which forms a triple complex with AMOTL1 and YAP1. A, Flag-tagged c-Abl (F.cAbl),
immobilized on M2 sepharose beads, precipitates Nedd4.2. Immunoprecipitates were blotted with anti-myc antibody. AIP4, E3 ligase was used as a
negative control. B, Protein-protein interactions among AMOTL1, Nedd4.2 and YAP1. HEK293T cells transfected with Flag-tagged AMOTL1,
myc.Nedd4.2, V5.YAP1 and V5.cAbl plasmids were lysed and immunoprecipitation was performed using M2 beads. Precipitates were blotted with the
antibodies indicated. Increased levels of AMOTL1 were detected in the presence of YAP1 and c-Abl. C, HEK293T cells were co-transfected with
myc.Nedd4.2 and either wild type or kinase-dead (KD) c-Abl. Immunoprecipitation was performed with anti-myc antibody. Samples were blotted with
anti-phosphotyrosine antibody to test for Nedd4.2 phosphorylation. D, Tyrosine phosphorylation of Nedd4.2 by c-Abl inhibits AMOTL1 degradation.
Flag-tagged AMOTL1 (F.AMOTL1) and myc-tagged Nedd4.2 (myc.Nedd4.2) were co-expressed with either wild type or kinase-dead Flag-tagged c-Abl
YAP1 Protects AMOTL1 from Degradation
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WW1 domain), prevented AMOTL1 from Nedd4.2-mediated
degradation (Fig. 4B). Because longer ubiquitin chains (poly-
ubiquitylation) are required for targeting to the 26S proteasome,
complexes migrating higher indicate strong degradation, whereas
complexes migrating lower (i.e. with shorter ubiquitin chains,
oligo-ubiquitylation) efficiently avoid being recognized and
degraded [28].
The N-terminal LPTY and PPEY binding motifs of AMOTL1
are important for binding to YAP1
WW domain-containing group I proteins such as YAP1 bind
with high affinity to proline-rich PPxY (PY) motifs [29], but also
recognize LPxY (LY) motifs [30,31,32]. For example, the group I
WW domain-containing protein MAGI-1 binds the LPTY motif
of AMOTL2 [33]. To identify the WW-binding motifs that are
recognized by YAP1, we replaced the two PY and the single LY
motifs of AMOTL1 by alanines. YAP1 precipitated the single and
double AMOTL1 PY mutants (data not shown) and protected
them from Nedd4.2-mediated ubiquitylation (Fig. 4C), suggesting
that these two motifs play only a minor role in the AMOTL1-
YAP1 complex. However, the combined LY/PY1 muta-
tion dramatically decreased the interaction with YAP1 (Fig. 6).
These findings demonstrate that AMOTL1 PPEY
310–313 and
LPTY
188–191 are jointly required for YAP1 binding.
Phosphorylation of Nedd4.2 by c-Abl inhibits
ubiquitylation of AMOTL1
YAP1 binds the SH3 domain of Src kinase family members, and
has been shown to interact with the non-receptor tyrosine kinase c-
Abl [34,35]. Because c-Abl phosphorylates and inactivates the E3-
ligase Parkin [36], we speculated that YAP1 recruits c-Abl to
phosphorylate and inhibit Nedd4.2 activity. Precipitation of c-Abl
immobilized Nedd4.2, but not the E3 ubiquitin ligase AIP4
(Fig. 7A). Moreover, YAP1 does not compete with Nedd4.2 for
binding to AMOTL1, but forms a multimeric protein complex
with Nedd4.2 and AMOTL1 (Fig. 7B). In addition, in the absence
of YAP1, c-Abl is able to protect AMOTL1 from degradation by
Nedd4.2 to some extent, although the simultaneous addition of
YAP1 significantly increases AMOTL1 stabilization (Fig. 7B).
Monitoring overall tyrosine-phosphorylation of Nedd4.2 revealed
that Nedd4.2 is phosphorylated on tyrosine residues in the
presence of wild type c-Abl, but not in the presence of the
kinase-dead c-Abl (c-Abl
K290R) (Fig. 7C). Consistent with our
hypothesis that tyrosine phosphorylation blocks Nedd4.2 E3 ligase
activity, we observed increased AMOTL1 levels in the presence of
wild-type c-Abl, but not in the presence of the kinase-dead c-Abl
mutant (Fig. 7D). To identify which Nedd4.2 tyrosine residues are
phosphorylated in the presence of c-Abl, we precipitated Nedd4.2
from cells expressing either wild-type c-Abl or c-Abl
K290R, and
subjected purified Nedd4.2 to mass spectrometry analysis. This
approach revealed two phosphorylation sites within the peptide
sequences WNEEFY*FR and DTLSNPQSPQPSPY*NSPK, cor-
responding to Y71 and Y457 of human Nedd4.2 (NCBI Accession
NP_001138441) (Fig. 8A). To validate the significance of Y71 or
Y457 phosphorylation, we replaced the two tyrosines of myc-
tagged Nedd4.2 with phenylalanines. Phosphorylation of Ned-
d4.2
Y71F and Nedd4.2
Y457F was not reduced; moderate reduction
in phosphorylation was only detected for the Nedd4.2
Y71F,Y457F
double mutant (Fig. 8B). To test whether the two Nedd4.2 tyrosine
residues are important for c-Abl-mediated inhibition of Nedd4.2
function, we assessed the ubiquitylation of AMOTL1 in the
presence of c-Abl with wild type and mutant Nedd4.2
Y71F,Y457F.
Nedd4.2 promoted the formation of poly-ubiquitylated AMOTL1
species with a molecular weight above 220 kDa. The presence of
c-Abl decreased the molecular weight range of ubiquitin-bound
AMOTL1 between 100 and 220 kDa, consistent with the
formation of AMOTL1 molecules with shorter ubiquitin chains
(oligo-ubiquitylation). Nedd4.2
Y71F,Y457F was resistant to the
action of c-Abl and polyubiquitylated AMOTL1 was produced
even in the presence of c-Abl (Fig. 8C). As previously explained for
Fig. 4B, longer ubiquitin chains (MW greater than 220 kDa)
indicate 26S proteasome-mediated degradation, whereas shorter
ubiquitin chains are not sufficient to target the protein for
degradation. The above findings support the hypothesis that c-Abl
mediates tyrosine phosphorylation to restrain the E3 ligase activity
of Nedd4.2.
Discussion
Recent studies have shown that different members of the
AMOT protein family (AMOT, AMOTL-1 and AMOTL-2)
exhibit similar function by interacting with and regulating YAP1
subcellular localization. However, the functional importance of
these family members can vary between cell lines and tissues,
depending on their relative expression levels [18,37]. Like AMOT,
AMOTL1 has been reported to be a tight junction-associated
protein [17]. Other studies support that YAP1 adopts tight
junction localization in polarized epithelial cells in an AMOT-
dependent manner [37]. Therefore, the role of YAP1 in tight
junction maintenance through the regulation of AMOTL1 is
intriguing.
Angiomotin proteins co-evolved with the advent of vascular
epithelium [38]. Since Drosophila melanogaster lacks continuous
vasculature, functional homologs of Angiomotin proteins are
absent in flies. Thus, cytoplasmic retention of Yorkie (YAP1)
appears to rely predominantly on Hippo signaling in Drosophila.
Polarized vertebrate cells expressing AMOT family members can
prevent nuclear translocation of YAP1 by recruiting this
transcriptional activator to tight junctions [18,19]. Our results,
however, highlight a novel and unexpected function of YAP1 at
tight junctions. While Nedd4.2 targets AMOTL1 for ubiquitin-
dependent degradation, YAP1 recruits c-Abl to facilitate phos-
phorylation and inhibition of Nedd4.2.
Our findings uncover a dual and opposing role for YAP1 in the
nucleus and the cytoplasm (Fig. 8D). Polarized non-dividing cells
need to maintain cell-cell contacts and epithelial integrity, which in
turn requires TJ-associated AMOTL1 and therefore cytoplasmic
YAP1. Cytoplasmic YAP1 in this case acts as an adaptor protein
that recruits the tyrosine kinase c-Abl to associate with Nedd4.2,
resulting in its phosphorylation at Y71 and Y457. This complex
then modulates Nedd4.2 activity such, that the length of ubiquitin
chains added on AMOTL1 is limited, protecting it from 26S
proteasome degradation. On the other hand, when cells undergo
proliferation, YAP1 translocates to the nucleus to associate with
TEAD family transcription factors, implicated in tumor growth
and metastasis [39]. Meanwhile, AMOTL1 is exposed to
degradation by Nedd4.2, which leads to TJ disassembly, required
in dividing cells.
(F.cAbl). Precipitates, immobilized with anti-myc antibody, were probed with anti-phosphotyrosine and with anti-myc antibody show equal amounts
of Nedd4.2; staining with anti-Flag revealed AMOTL1 protein levels.
doi:10.1371/journal.pone.0035735.g007
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Figure S1 Domain structure of AMOTL1, YAP1 and
Nedd4.2. WW domains in AMOTL1 and Nedd4.2 protein
sequence are indicated with blue rhombs. c-c, coiled coli domains;
P-rich, proline rich domains; C2, C2-domain; HECTc, Homol-
ogous to the E6-AP Carboxyl Terminus domain.
(TIF)
Figure S2 YAP1 protects AMOTL1 against Nedd4.2-
mediated protein turnover. F.AMOTL1, and myc.Nedd4.2
were co-expressed with increasing amounts of V5.YAP1 (1 mg,
3 mg and 6 mg). Western blot analysis with anti-Flag revealed
increasing AMOTL1 levels despite the presence of myc.Nedd4.2.
Actin was used as a loading control.
(TIF)
Figure S3 The WW1 domain of YAP1 is required for
binding and stabilization of AMOTL1. A, Endogenous
AMOTL1 was strongly precipitated by a mouse anti-YAP1
antibody. B, Immunostaining in HEK293T cells using anti-
AMOTL1 and anti-YAP1 antibodies revealed that the two
proteins localize to the cell membrane. C, YAP1 WW1 and
WW2 mutants were co-expressed with AMOTL1 in HEK 293T
cells. AMOTL1 was precipitated with anti-Flag. YAP1WW2, but
not YAP1WW1 was immobilized by AMOTL1, and detected by
anti-V5 antibody. GFP was used as a negative control. Scale bars
represent 20 mm.
(TIF)
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